Expectedly, the increase in monocytic sCD163 production which we observed upon stimulation with ischemic stroke serum was largely ablated by treatment with Marimastat (Fig. 4E), inferring that it was generated via the canonical sCD163 pathway involving ADAM17. Here, ADAM17 is linked to ischemic stroke.